NEW YORK, NY / ACCESSWIRE / April 20, 2016 / DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) today published a new blog post on The Chairman's Blog, written by the Company's Chief Executive Officer, Jeffrey Bacha. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.
In his new blog, DelMar CEO discusses recently presented data from collaborators at MD Anderson Cancer Center and the University of British Columbia during the 2016 Annual Meeting of the American Association for Cancer Research which showed the mechanism of VAL-083 to be unique from other chemotherapies. Mr. Bacha highlights the importance of the new data and how it supports VAL-083's potential to target resistant cancers as well as to be successfully used in combination therapy. He goes on to explain the unique anti-cancer activity of VAL-083 and how it appears to take advantage of the "very essence of what makes a cancer cell a cancer cell." Read the full blog post from Mr. Bacha on TheChairmansBlog.com (http://www.thechairmansblog.com/delmar-pharmaceuticals/jeffrey-bacha/mechanism-matters/).
About DelMar Pharmaceuticals, Inc.
DelMar Pharmaceuticals, Inc. was founded to develop and commercialize new cancer therapies in indications where patients are failing or have become intolerable to modern targeted or biologic treatments. The Company's lead drug in development, VAL-083, is currently undergoing clinical trials in the U.S. as a potential treatment for refractory glioblastoma multiforme. VAL-083 has been extensively studied by U.S. National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a novel mechanism of action that could provide improved treatment options for patients.
About TheChairmansBlog.com
TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com
SOURCE: TheChairmansBlog.com
ReleaseID: 439043
